Obagi 360 (OMP, Inc.)
Welcome to the PulseAid listing for the Obagi 360 drug offered from OMP, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | OMP, Inc. |
NON-PROPRIETARY NAME: | Avobenzone, Octinoxate, Octisalate, Oxybenzone |
SUBSTANCE NAME: | |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2015-09-08 |
END MARKETING DATE: | 0000-00-00 |
Obagi 360 HUMAN OTC DRUG Details:
Item Description | Obagi 360 from OMP, Inc. |
LABELER NAME: | OMP, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2015-09-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62032-580_4fa39b43-7a13-47de-88d6-6398a38c9de5 |
PRODUCT NDC: | 62032-580 |
APPLICATION NUMBER: | part352 |